title: Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease.
authors.forename: Daniel
authors.initials: D
authors.lastname: El Fassi
authors.forename: Claus H
authors.initials: CH
authors.lastname: Nielsen
authors.forename: Jens
authors.initials: J
authors.lastname: Kjeldsen
authors.forename: Ole
authors.initials: O
authors.lastname: Clemmensen
authors.forename: Laszlo
authors.initials: L
authors.lastname: Hegedüs
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001402:B-Lymphocytes / Q000187:drug effects*; D003093:Colitis, Ulcerative / Q000139:chemically induced*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D008231:Lymphopenia / Q000139:chemically induced*; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab